No association between proton pump inhibitor use and ALS risk: a nationwide nested case–control study

The use of proton pump inhibitors (PPIs) has been proposed as a potential risk factor for neurodegenerative diseases, but little is known regarding its role in amyotrophic lateral sclerosis (ALS). We therefore aimed to assess the association of PPI use with the subsequent risk of ALS, and performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Cetin, Hakan, Sun, Jiangwei, Almqvist, Catarina, Reichardt, Berthold, Tomschik, Matthias, Zimprich, Fritz, Fang, Fang, Ingre, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414209/
https://www.ncbi.nlm.nih.gov/pubmed/32770128
http://dx.doi.org/10.1038/s41598-020-70373-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414209/
https://www.ncbi.nlm.nih.gov/pubmed/32770128
http://dx.doi.org/10.1038/s41598-020-70373-8

Ejemplares similares